International Multiple Sclerosis Genetics Consortium: Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:851, 2007.
Jacobs L, Kinkel PR, Kinkel WR: Silent brain lesions in patients with isolated idiopathic optic neuritis. Arch Neurol 43:452, 1986.
Johnson RT, Griffin DE, Hirsch RL, et al: Measles encephalomyelitis: Clinical and immunologic studies. N Engl J Med 310:137, 1984.
Kanter DS, Horensky D, Sperling RA, et al: Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 45:824, 1995.
Kappos L, Antel J, Comi G, et al: Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 355:1124, 2006.
Kappos L, Li D, Calabresi PA, et al: Ocrelizumab in relapsing-remitting multiple sclerosis: A phase 2, randomised, placebo-controlled multicentre trial. Lancet 378:1779, 2011.
Kappos L, Radue EW, O’Connor P, et al; FREEDOMS Study Group: A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362:387, 2010.
Katz J, Ropper AH: Progressive necrotic myelopathy: Clinical course in 9 patients. Arch Neurol 57:355, 2000.
Kepes JJ: Large focal tumor-like demyelinating lesions of the brain: Intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis: A study of 31 patients. Ann Neurol 33:18, 1993.
Kidd D, Burtan B, Plant GT, et al: Chronic relapsing inflammatory optic neuropathy. Brain 126:276, 2003.
Koelman DL, Chahin S, Mar SS, et al: Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study. Neurology 31:2085, 2016.
Kuhle J, Pohl C, Mehling M, et al: Lack of association between antimyelin antibodies and progression to multiple sclerosis.
N Engl J Med 356:371, 2007.
Kurland LT: The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada. Am J Hyg 55:457, 1952.
Kurtzke JF: A reassessment of the distribution of multiple sclerosis. Act Neurol Scand 51:110, 1975.
Kurtzke JF, Gudmundsson KR, Bergmann S: Multiple sclerosis in Iceland: I. Evidence of a post-war epidemic. Neurology 32:143, 1982.
Kurtzke JF, Hyllested K: Multiple sclerosis in the Faroe Islands: II. Clinical update, transmission, and the nature of MS. Neurology 36:307, 1986.
Lennon VA, Wingerchuk DM, Kryzer TJ, et al: A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 364:2106, 2004.